MDXHEALTH SA Research and Development Expense
MDXHEALTH SA (MDXH) reported Research and Development Expense of $10.35 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-04-03
| Period end | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.35M 20-F · filed 2026-04-03 | |
| 2024-12-31 | $10.55M 20-F · filed 2026-04-03 | |
| 2023-12-31 | $6.38M 20-F · filed 2026-04-03 | |
| 2022-12-31 | $5.50M 20-F · filed 2025-03-31 | $7.56M 20-F · filed 2023-04-25 |
| 2021-12-31 | $5.59M 20-F · filed 2024-04-30 | $6.67M 20-F · filed 2022-04-25 |
| 2020-12-31 | $4.54M 20-F · filed 2023-04-25 | |
| 2019-12-31 | $9.00M 20-F · filed 2022-04-25 |